Lexaria Bioscience Corp.: Lexaria Updates its Ongoing Human Study GLP-1-H24-4
Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss KELOWNA, BC / ACCESS Newswire / February 5, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "L ...
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss KELOWNA, BC / ACCESS Newswire / February 5, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or ...
Novo Nordisk (NVO) Q4 2024 Earnings Call Transcript
Welcome to the full-year 2024 Novo Nordisk earnings conference call. [Operator instructions] Please be advised that today's ...
Lexaria Bioscience Corp.: Lexaria Releases Annual Letter from the CEO
KELOWNA, BC / ACCESS Newswire / January 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provi ...
Amy Schumer Lost 30 Lbs. on Ozempic — 'I Looked Great' — but Quit After Being ‘Bedridden’ with Nausea
Actress and comedian Amy Schumer said she took Ozempic three years ago and quickly lost 30 lbs. However, she quit the ...
Weight loss jabs hit with stricter rules as people with eating disorders get online prescriptions
The General Pharmaceutical Council (GPhC) has introduced new rules for weight-loss jabs, such as Wegovy and Mounjaro, in ...
Pharmacies require stricter weight-loss jab checks
Online pharmacies will now have to employ stricter checks to stop people who are already a healthy weight or have a history ...
Lexaria reports promising drug delivery study results
KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX), a leader in drug delivery platforms with a market capitalization of $31.77 million, has announced significant advancements in its DehydraTECH ...
pharmaphorum5d
Novo Nordisk, Lilly highlight oral obesity drugs at ADA
Two-thirds (69%) of semaglutide-treated patients lost 10% of their body weight, compared to 12% of the placebo arm. Similarly, a third (34%) of them lost 20%, compared to 3% of controls.
Yahoo Style UK1d
What to know before considering weight loss jabs, as patients face further checks
Wegovy is the brand name for semaglutide which is licensed and approved for managing ... pen that is to be injected under the skin of your stomach area, thigh or upper arm. The starting dose is 2.5mg ...
verywellhealth4d
Comparing Victoza vs. Ozempic for Diabetes and Weight Loss
Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs used to treat ... You give yourself a shot either in the abdomen, thigh, or upper arm. One of the main differences between ...
Yahoo Finance3d
Arm Holdings plc (ARM)
Despite the challenging outlook, Vinh highlights Nvidia (NVDA), Arm Holdings (ARM), and On Semiconductor (ON) as stocks positioned to potentially outperform in this scenario. To watch more expert ...